vs
LCI INDUSTRIES（LCII）与莫德纳（MRNA）财务数据对比。点击上方公司名可切换其他公司
莫德纳的季度营收约是LCI INDUSTRIES的1.1倍（$1.0B vs $932.7M），LCI INDUSTRIES净利率更高（2.0% vs -19.7%，领先21.7%），LCI INDUSTRIES同比增速更快（16.1% vs -45.4%），LCI INDUSTRIES自由现金流更多（$64.3M vs $-880.0M），过去两年LCI INDUSTRIES的营收复合增速更高（-1.8% vs -45.0%）
拉奇核心工业有限公司前身为巴基斯坦帝国化学工业公司，是一家总部位于卡拉奇的巴基斯坦综合性企业集团，业务覆盖聚酯、医药、农用化学品、纯碱及兽药等多品类产品的研发生产，在巴基斯坦本土工业领域拥有重要市场地位。
莫德纳是一家总部位于美国马萨诸塞州剑桥市的生物制药企业，深耕RNA治疗领域，核心业务聚焦mRNA疫苗研发。其疫苗通过信使RNA（mRNA）分子拷贝传递蛋白合成指令以触发人体免疫反应，公司名称由“修饰”“RNA”与“现代”三个词组合而来。
LCII vs MRNA — 直观对比
营收规模更大
MRNA
是对方的1.1倍
$932.7M
营收增速更快
LCII
高出61.6%
-45.4%
净利率更高
LCII
高出21.7%
-19.7%
自由现金流更多
LCII
多$944.3M
$-880.0M
两年增速更快
LCII
近两年复合增速
-45.0%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $932.7M | $1.0B |
| 净利润 | $18.7M | $-200.0M |
| 毛利率 | 22.1% | 79.6% |
| 营业利润率 | 3.8% | -25.6% |
| 净利率 | 2.0% | -19.7% |
| 营收同比 | 16.1% | -45.4% |
| 净利润同比 | 95.7% | -1638.5% |
| 每股收益（稀释后） | $0.79 | $-0.51 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LCIIMRNA
| Q4 25 | $932.7M | — | ||
| Q3 25 | $1.0B | $1.0B | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.0B | — | ||
| Q4 24 | $803.1M | $966.0M | ||
| Q3 24 | $915.5M | $1.9B | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $968.0M | — |
净利润LCIIMRNA
| Q4 25 | $18.7M | — | ||
| Q3 25 | $62.5M | $-200.0M | ||
| Q2 25 | $57.6M | — | ||
| Q1 25 | $49.4M | — | ||
| Q4 24 | $9.5M | $-1.1B | ||
| Q3 24 | $35.6M | $13.0M | ||
| Q2 24 | $61.2M | — | ||
| Q1 24 | $36.5M | — |
毛利率LCIIMRNA
| Q4 25 | 22.1% | — | ||
| Q3 25 | 24.4% | 79.6% | ||
| Q2 25 | 24.4% | — | ||
| Q1 25 | 24.1% | — | ||
| Q4 24 | 21.1% | 23.5% | ||
| Q3 24 | 24.0% | 72.4% | ||
| Q2 24 | 25.3% | — | ||
| Q1 24 | 23.1% | — |
营业利润率LCIIMRNA
| Q4 25 | 3.8% | — | ||
| Q3 25 | 7.3% | -25.6% | ||
| Q2 25 | 7.9% | — | ||
| Q1 25 | 7.8% | — | ||
| Q4 24 | 2.0% | -129.0% | ||
| Q3 24 | 5.9% | -3.8% | ||
| Q2 24 | 8.6% | — | ||
| Q1 24 | 6.0% | — |
净利率LCIIMRNA
| Q4 25 | 2.0% | — | ||
| Q3 25 | 6.0% | -19.7% | ||
| Q2 25 | 5.2% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 1.2% | -115.9% | ||
| Q3 24 | 3.9% | 0.7% | ||
| Q2 24 | 5.8% | — | ||
| Q1 24 | 3.8% | — |
每股收益（稀释后）LCIIMRNA
| Q4 25 | $0.79 | — | ||
| Q3 25 | $2.55 | $-0.51 | ||
| Q2 25 | $2.29 | — | ||
| Q1 25 | $1.94 | — | ||
| Q4 24 | $0.37 | $-2.91 | ||
| Q3 24 | $1.39 | $0.03 | ||
| Q2 24 | $2.40 | — | ||
| Q1 24 | $1.44 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $222.6M | $1.1B |
| 总债务越低越好 | $945.2M | — |
| 股东权益账面价值 | $1.4B | $9.3B |
| 总资产 | $3.2B | $12.1B |
| 负债/权益比越低杠杆越低 | 0.69× | — |
8季度趋势，按日历期对齐
现金及短期投资LCIIMRNA
| Q4 25 | $222.6M | — | ||
| Q3 25 | $199.7M | $1.1B | ||
| Q2 25 | $191.9M | — | ||
| Q1 25 | $231.2M | — | ||
| Q4 24 | $165.8M | $1.9B | ||
| Q3 24 | $161.2M | $1.6B | ||
| Q2 24 | $130.4M | — | ||
| Q1 24 | $22.6M | — |
总债务LCIIMRNA
| Q4 25 | $945.2M | — | ||
| Q3 25 | $947.8M | — | ||
| Q2 25 | $948.0M | — | ||
| Q1 25 | $938.3M | — | ||
| Q4 24 | $757.3M | — | ||
| Q3 24 | $822.5M | — | ||
| Q2 24 | $829.7M | — | ||
| Q1 24 | $855.3M | — |
股东权益LCIIMRNA
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | $9.3B | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.4B | $10.9B | ||
| Q3 24 | $1.4B | $11.9B | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.4B | — |
总资产LCIIMRNA
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.2B | $12.1B | ||
| Q2 25 | $3.2B | — | ||
| Q1 25 | $3.1B | — | ||
| Q4 24 | $2.9B | $14.1B | ||
| Q3 24 | $3.0B | $15.8B | ||
| Q2 24 | $3.0B | — | ||
| Q1 24 | $3.0B | — |
负债/权益比LCIIMRNA
| Q4 25 | 0.69× | — | ||
| Q3 25 | 0.70× | — | ||
| Q2 25 | 0.68× | — | ||
| Q1 25 | 0.69× | — | ||
| Q4 24 | 0.55× | — | ||
| Q3 24 | 0.58× | — | ||
| Q2 24 | 0.60× | — | ||
| Q1 24 | 0.63× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $78.9M | $-847.0M |
| 自由现金流经营现金流 - 资本支出 | $64.3M | $-880.0M |
| 自由现金流率自由现金流/营收 | 6.9% | -86.6% |
| 资本支出强度资本支出/营收 | 1.6% | 3.2% |
| 现金转化率经营现金流/净利润 | 4.22× | — |
| 过去12个月自由现金流最近4个季度 | $278.3M | $-1.9B |
8季度趋势，按日历期对齐
经营现金流LCIIMRNA
| Q4 25 | $78.9M | — | ||
| Q3 25 | $97.2M | $-847.0M | ||
| Q2 25 | $112.2M | — | ||
| Q1 25 | $42.7M | — | ||
| Q4 24 | $106.6M | $825.0M | ||
| Q3 24 | $78.4M | $-1.6B | ||
| Q2 24 | $192.9M | — | ||
| Q1 24 | $-7.7M | — |
自由现金流LCIIMRNA
| Q4 25 | $64.3M | — | ||
| Q3 25 | $80.9M | $-880.0M | ||
| Q2 25 | $99.5M | — | ||
| Q1 25 | $33.7M | — | ||
| Q4 24 | $95.7M | $303.0M | ||
| Q3 24 | $68.3M | $-1.7B | ||
| Q2 24 | $180.2M | — | ||
| Q1 24 | $-16.3M | — |
自由现金流率LCIIMRNA
| Q4 25 | 6.9% | — | ||
| Q3 25 | 7.8% | -86.6% | ||
| Q2 25 | 9.0% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 11.9% | 31.4% | ||
| Q3 24 | 7.5% | -92.2% | ||
| Q2 24 | 17.1% | — | ||
| Q1 24 | -1.7% | — |
资本支出强度LCIIMRNA
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.6% | 3.2% | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 1.4% | 54.0% | ||
| Q3 24 | 1.1% | 8.1% | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 0.9% | — |
现金转化率LCIIMRNA
| Q4 25 | 4.22× | — | ||
| Q3 25 | 1.55× | — | ||
| Q2 25 | 1.95× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 11.17× | — | ||
| Q3 24 | 2.20× | -120.46× | ||
| Q2 24 | 3.15× | — | ||
| Q1 24 | -0.21× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LCII
| Travel Trailer And Fifth Wheels | $378.4M | 41% |
| Chassis Chassis Partsand Slideout Mechanisms | $206.1M | 22% |
| Furnitureand Mattresses | $120.4M | 13% |
| Appliances | $69.9M | 7% |
| Other Products | $69.1M | 7% |
| Axlesand Suspension Solutions | $62.3M | 7% |
| Motorhomes | $34.2M | 4% |
MRNA
| COVID19 | $971.0M | 96% |
| Other Revenue | $20.0M | 2% |
| Grant | $14.0M | 1% |
| Collaboration Arrangement Including Arrangements With Affiliate | $7.0M | 1% |
| License And Royalty | $2.0M | 0% |
